Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Lysis & Disruption Market

Cell Lysis & Disruption Market Share

  • Report ID: GMI7723
  • Published Date: Dec 2023
  • Report Format: PDF
 Download Free Sample

Cell Lysis & Disruption Market Share

The cell lysis and disruption industry is characterized by diverse players competing in the industry, leveraging their research capabilities and global presence. Strategic collaborations, product innovations, and regulatory compliance further strengthen their positions. Also, the market is characterized by ongoing technological advancements and a focus on developing safer and more effective products, further intensifying the competitive dynamics in the healthcare sector.
 

Cell Lysis & Disruption Market Companies

Prominent players operating in the cell lysis and disruption industry is as mentioned below:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Danaher Corporation
  • Miltenyi Biotec
  • Claremont BioSolutions, LLC
  • IDEX
  • Parr Instrument Company
  • Covaris, LLC
  • Cell Signaling Technology, Inc.
  • Qsonica
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cell lysis & disruption industry size was valued USD 5.1 billion in 2023 and is expected to reach USD 10.9 billion by 2032, attributed to the expanding biopharmaceutical sector with focus on producing therapeutic proteins, monoclonal antibodies, and vaccines.

The reagent-based segment is expected to account for a revenue of USD 5.9 billion by 2032, these methods offer a cost-effective, simplified, and user-friendly approach, eliminating the need for complex equipment and specialized skills.

In 2023, North America held a significant market share of 37.9% and is anticipated to present lucrative opportunities over 2023-2032, backed by a robust infrastructure supporting cutting-edge R&D, a thriving biotechnology industry, and a well-established healthcare ecosystem.

Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Danaher Corporation, Miltenyi Biotec, Claremont BioSolutions, LLC, and IDEX.

Cell Lysis & Disruption Market Scope

  • Cell Lysis & Disruption Market Size
  • Cell Lysis & Disruption Market Trends
  • Cell Lysis & Disruption Market Analysis
  • Cell Lysis & Disruption Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 13
    • Tables & Figures: 532
    • Countries covered: 19
    • Pages: 250
     Download Free Sample
    ×
    Get a free sample of Cell Lysis & Disruption Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.